Since 2006, PCM Scientific has specialised in providing expert-driven IME and accredited CME programmes that result in measurable and sustained clinical practice improvements across a variety of therapy areas. Our fully integrated in-house services offer everything from digital media to logistics.
We have an impressive track record in the delivery of large-scale, international IME/CME initiatives that improve multi-disciplinary healthcare provision.
From community / primary care to secondary care and beyond, our combination of international healthcare professional communities, along with a partnership portfolio of market-leading media brands, places PCM Scientific at the heart of a highly engaged global community of multi-disciplinary healthcare providers.
On-demand, digestible education to support healthcare professionals stay abreast of evolving best practice in cardiology care. The programmes explore emerging data surrounding anti-coagulation, heart failure and hypertrophic cardiomyopathy. Explore
A compelling, avant-garde educational cascade for GPs, family physicians, nurses, and community cardiology teams. It was created with leading experts to support timely diagnosis and best practice care for people living with hypertrophic cardiomyopathy (HCM). Explore
A cutting-edge approach: dynamic, multi-format educational activities designed to enhance Attitude, Skills, and Knowledge (ASK) among members of the oncology multi-disciplinary team (MDT), including hospital-based pharmacists, nurses and oncologists. Explore
Inspiring and media-rich, interactive eLearning modules created with oncology nurse specialists, to meet the needs of European oncology nurses and help them overcome day-to-day challenges in practice. Explore
Spanning more than two decades, a pioneering international education initiative to improve opioid dependence healthcare through a variety of programmes – an annual conference, webinars, the take-home naloxone (THN) toolkit, practice reports and other digital resources. Explore
We are passionate about what we do and proud of what we achieve. And why not? With our international expert partnerships, our educational activities have achieved a lot. We work hard to create and deliver engaging and effective live and online programmes. Our innovative concepts make learning accessible and impactful. The outcome? Our programmes improve healthcare.
Launched in 2021, HCM Academy is a ground-breaking digital CME programme, created with expert faculty that has demonstrably improved clinician understanding and confidence around hypertrophic cardiomyopathy (HCM) diagnosis and management. The US pilot phase comprised expert-cascaded, peer-to-peer training, complimented by online resources. Reaching over 126,000 professionals and delivering 71 live digital workshops, the education has achieved knowledge and competency gains of up to 34% and 39% (respectively), and is being expanded for an international audience in 2023.
Targeting oncologists and hospital pharmacists, ASK online education has reached over 16,000 across the UK, Germany, Spain, France, Italy, Japan. Building on the initial programme success, new resources are being rolled-out for a world-wide learner audience to include Real-World Evidence case studies and abstract summaries. Alongside our expert faculty, we’re delighted that 100% of learners say they want to engage with future ASK education – proof of quality for this innovative approach that serves the oncology multi-disciplinary team with the latest knowledge in oncology biosimilars.
Returning for its 20th annual conference in 2022, IOTOD attracted over 790 live and on-demand delegates from 27 countries. Learners engaged with 15 expert international speakers during the 2-day, CME-accredited virtual event covering priority topics in the treatment of opioid dependence. Since 2001, IOTOD conference has delivered year-on-year practice-changing education and attracted over 6,500 delegates from around the world.
These revolutionary patient-focused resources have been created with renowned specialists to encourage healthcare provider discussions surrounding fertility and support patients recently diagnosed with leukaemia. Frequently asked question leaflets (FAQs) and videos (specific to female and male patients) have reached over 6,500 across Europe and the UK, since launch in August 2022. Featuring information to help patients understand the effects of blood cancer on fertility, the content offers different ways to support fertility preservation.
